Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07630896 · ClinicalTrials.gov registry record · Phase 4
Post-op Prednisone and Glucose Monitoring in TKA
A Phase 4 study, sponsored by Columbia University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT07630896 is a Phase 4 study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 104 participants.
The verdict
NCT07630896, a Phase 4 study, has not yet begun recruiting, sponsored by Columbia University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
Interventions
- DEVICE Continuous Glucose Monitor
- DRUG Prednisone
- OTHER InkWell Health Tattoos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07630896
The ClinicalTrials.gov registry entry for NCT07630896 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Continuous Glucose Monitor is the first listed.
NCT07630896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07630896 about?
NCT07630896 is a clinical study titled "Post-op Prednisone and Glucose Monitoring in TKA". This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
What is the current status of trial NCT07630896?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2026-07-01. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07630896?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Prednisone (DRUG), InkWell Health Tattoos (OTHER).
Who is sponsoring clinical trial NCT07630896?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.